PATENT CLAIM ANALYSIS

Application Number: 15761012
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "190100"]

Abstract:
The present invention provides antigens, for use in the treatment or prevention of  C. burnetii  infection. Also provided are nucleic acids encoding such antigens, and antibodies raised against such antigens.

Claim (Index 25):
A nucleic acid encoding one or more protein antigens according to  claim 1 , wherein said nucleic acid has been optimised for expression in a host cell.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 90.0
- Lexical Diversity: 1.17241
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12557741', '11837264', '12614896', '14396881', '12988595']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7093566105626138
- 35 USC 102 Novelty (BERT): 0.5207392331922406
- Combined Prediction Score: 0.6904948728255764
- Mean Citation Score: 259.467096
- Max Citation Score: 263.20352
- Similarity Product: 162.7695533940697

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test